These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 36983034)

  • 21. Subtherapeutic Doses of Vancomycin Synergize with Bacteriophages for Treatment of Experimental Methicillin-Resistant
    Save J; Que YA; Entenza J; Resch G
    Viruses; 2022 Aug; 14(8):. PubMed ID: 36016414
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isolation, characterization, therapeutic potency, and genomic analysis of a novel bacteriophage vB_KshKPC-M against carbapenemase-producing Klebsiella pneumoniae strains (CRKP) isolated from Ventilator-associated pneumoniae (VAP) infection of COVID-19 patients.
    Mohammadi M; Saffari M; Siadat SD; Hejazi SH; Shayestehpour M; Motallebi M; Eidi M
    Ann Clin Microbiol Antimicrob; 2023 Feb; 22(1):18. PubMed ID: 36829156
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Isolation and characterisation of a novel Silviavirus bacteriophage promising antimicrobial agent against methicillin-resistant Staphylococcus aureus infections.
    Lerdsittikul V; Apiratwarrasakul S; Atithep T; Withatanung P; Indrawattana N; Pumirat P; Chaiwattanarungruengpaisan S; Thongdee M
    Sci Rep; 2024 Apr; 14(1):9251. PubMed ID: 38649443
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Searching for synergy: combining systemic daptomycin treatment with localised phage therapy for the treatment of experimental pneumonia due to MRSA.
    Valente LG; Federer L; Iten M; Grandgirard D; Leib SL; Jakob SM; Haenggi M; Cameron DR; Que YA; Prazak J
    BMC Res Notes; 2021 Sep; 14(1):381. PubMed ID: 34579784
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Isolation and characterization of lytic bacteriophages from sewage at an egyptian tertiary care hospital against methicillin-resistant
    Samir S; El-Far A; Okasha H; Mahdy R; Samir F; Nasr S
    Saudi J Biol Sci; 2022 May; 29(5):3097-3106. PubMed ID: 35360502
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transcriptional Landscapes of
    Kornienko M; Bespiatykh D; Gorodnichev R; Abdraimova N; Shitikov E
    Viruses; 2023 Jun; 15(7):. PubMed ID: 37515114
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microcalorimetry: A Novel Application to Measure In Vitro Phage Susceptibility of
    Molendijk MM; Phan MVT; Bode LGM; Strepis N; Prasad DK; Worp N; Nieuwenhuijse DF; Schapendonk CME; Boekema BKHL; Verbon A; Koopmans MPG; Graaf M; van Wamel WJB
    Viruses; 2022 Dec; 15(1):. PubMed ID: 36680055
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phage JS02, a putative temperate phage, a novel biofilm-degrading agent for Staphylococcus aureus.
    Zhang L; Shahin K; Soleimani-Delfan A; Ding H; Wang H; Sun L; Wang R
    Lett Appl Microbiol; 2022 Sep; 75(3):643-654. PubMed ID: 35100443
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bacteriophage Therapy for the Prevention and Treatment of Fracture-Related Infection Caused by Staphylococcus aureus: a Preclinical Study.
    Onsea J; Post V; Buchholz T; Schwegler H; Zeiter S; Wagemans J; Pirnay JP; Merabishvili M; D'Este M; Rotman SG; Trampuz A; Verhofstad MHJ; Obremskey WT; Lavigne R; Richards RG; Moriarty TF; Metsemakers WJ
    Microbiol Spectr; 2021 Dec; 9(3):e0173621. PubMed ID: 34908439
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization and comprehensive genome analysis of novel bacteriophage, vB_Kpn_ZCKp20p, with lytic and anti-biofilm potential against clinical multidrug-resistant
    Zaki BM; Fahmy NA; Aziz RK; Samir R; El-Shibiny A
    Front Cell Infect Microbiol; 2023; 13():1077995. PubMed ID: 36756618
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isolation and characterization of a potentially novel Siphoviridae phage (vB_SsapS-104) with lytic activity against Staphylococcus saprophyticus isolated from urinary tract infection.
    Yazdi M; Bouzari M; Ghaemi EA
    Folia Microbiol (Praha); 2019 May; 64(3):283-294. PubMed ID: 30284669
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lytic bacteriophages against multidrug-resistant Staphylococcus aureus, Enterococcus faecalis and Escherichia coli isolates from orthopaedic implant-associated infections.
    Barros J; Melo LDR; Poeta P; Igrejas G; Ferraz MP; Azeredo J; Monteiro FJ
    Int J Antimicrob Agents; 2019 Sep; 54(3):329-337. PubMed ID: 31229670
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potential of bacteriophages as disinfectants to control of Staphylococcus aureus biofilms.
    Song J; Ruan H; Chen L; Jin Y; Zheng J; Wu R; Sun D
    BMC Microbiol; 2021 Feb; 21(1):57. PubMed ID: 33607940
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Strategy for mass production of lytic Staphylococcus aureus bacteriophage pSa-3: contribution of multiplicity of infection and response surface methodology.
    Kim SG; Kwon J; Giri SS; Yun S; Kim HJ; Kim SW; Kang JW; Lee SB; Jung WJ; Park SC
    Microb Cell Fact; 2021 Mar; 20(1):56. PubMed ID: 33653327
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bacteriophage effectively kills multidrug resistant Staphylococcus aureus clinical isolates from chronic rhinosinusitis patients.
    Zhang G; Zhao Y; Paramasivan S; Richter K; Morales S; Wormald PJ; Vreugde S
    Int Forum Allergy Rhinol; 2018 Mar; 8(3):406-414. PubMed ID: 29240296
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Susceptibility of Staphylococcus aureus strains to commercial therapeutic phage preparations.
    Straka M; Hubenakova Z; Lichvarikova A; Janosikova L; Markuskova B; Minich A; Liptakova A; Drahovska H; Slobodnikova L
    Bratisl Lek Listy; 2022; 123(10):724-729. PubMed ID: 35913007
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bacteriophages Improve Outcomes in Experimental
    Prazak J; Iten M; Cameron DR; Save J; Grandgirard D; Resch G; Goepfert C; Leib SL; Takala J; Jakob SM; Que YA; Haenggi M
    Am J Respir Crit Care Med; 2019 Nov; 200(9):1126-1133. PubMed ID: 31260638
    [No Abstract]   [Full Text] [Related]  

  • 38. Overcoming bacteriophage insensitivity in Staphylococcus aureus using clindamycin and azithromycinat subinhibitory concentrations.
    Liu S; Zhao Y; Hayes A; Hon K; Zhang G; Bennett C; Hu H; Finnie J; Morales S; Shearwin L; Psaltis AJ; Shearwin K; Wormald PJ; Vreugde S
    Allergy; 2021 Nov; 76(11):3446-3458. PubMed ID: 33930199
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization and complete genome sequence analysis of a novel virulent Siphoviridae phage against Staphylococcus aureus isolated from bovine mastitis in Xinjiang, China.
    Zhang Q; Xing S; Sun Q; Pei G; Cheng S; Liu Y; An X; Zhang X; Qu Y; Tong Y
    Virus Genes; 2017 Jun; 53(3):464-476. PubMed ID: 28299517
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Simple Two-step, High Yield Protocol for Isolation and Amplification of Bacteriophages Against Methicillin-resistant Staphylococcus Aureus (MRSA).
    Khan A; Joshi H
    Curr Protoc; 2022 Mar; 2(3):e395. PubMed ID: 35259286
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.